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Abstract: By using interdigital microfluidic reactors, monodisperse poly(d,l lactic-co-glycolic 
acid) nanoparticles (NPs) can be produced in a continuous manner and at a large scale (∼10 g/h). 
An optimized synthesis protocol was obtained by selecting the appropriated passive mixer and 
fluid flow conditions to produce monodisperse NPs. A reduced NP polydispersity was obtained 
when using the microfluidic platform compared with the one obtained with NPs produced in 
a conventional discontinuous batch reactor. Cyclosporin, an immunosuppressant drug, was 
used as a model to validate the efficiency of the microfluidic platform to produce drug-loaded 
monodisperse poly(d,l lactic-co-glycolic acid) NPs. The influence of the mixer geometries and 
temperatures were analyzed, and the experimental results were corroborated by using compu-
tational fluid dynamic three-dimensional simulations. Flow patterns, mixing times, and mixing 
efficiencies were calculated, and the model supported with experimental results. The progress 
of mixing in the interdigital mixer was quantified by using the volume fractions of the organic 
and aqueous phases used during the emulsification–evaporation process. The developed model 
and methods were applied to determine the required time for achieving a complete mixing in 
each microreactor at different fluid flow conditions, temperatures, and mixing rates.
Keywords: microchannel emulsification, high-throughput synthesis, drug-loaded polymer 
nanoparticles, passive mixing, numerical modeling
Introduction
Poly(d,l lactic-co-glycolic acid) (PLGA) is a commercially available biodegradable 
polymer widely used in drug delivery applications such as vaccinations,1–3 cancer 
treatment,4–6 and management of inflammatory diseases.7–9 Among the different 
polymers developed for biomedical applications, PLGA has attracted considerable 
attention due to its interesting properties:10 1) predictable biodegradability and 
biocompatibility, 2) US Food and Drug Administration and European Medicine Agency 
approvals for its drug delivery systems intended for parenteral administration, 3) well-
described formulations and methods of production adapted to the encapsulation of 
various types of hydrophilic or hydrophobic active pharmaceutical ingredients, 4) drug 
protection from biochemical degradation, 5) possibility to target its based nanoparticles 
(NPs) to specific tissues or cells, 6) possibility of sustained release, and 7) possibility 
to easily modify its surface properties.
In liquid phase, PLGA NPs are generally prepared using single or double emulsion 
solvent evaporation techniques, nanoprecipitation, membrane emulsification, spontane-
ous emulsion solvent diffusion techniques, and microfluidic reactors. Their degradation 
rates can be tuned depending on the polymer molecular weight and the copolymer 
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composition. Physical methods such as spray-drying, 
supercritical antisolvent precipitation, electrospining, and 
so on can also be used for their formulation. Despite the 
current advances in the design of PLGA-based NPs, their 
translation into the clinic has been slow because it remains 
challenging to produce NPs that are consistent “batch-to-
batch”,11 easily reconstituted after lyophilization and in 
sufficient quantities for clinical production scale.12 In fact, 
the strict quality requirements on the characteristics of NPs 
pose serious challenges to their mass production, including 
limited batch-to-batch reproducibility and controllability, 
in terms of morphological and physicochemical properties. 
A wide variety of multistep batch laboratory procedures are 
not amenable to large-scale production,11 and there is often 
a balance between maintaining the ability to control the 
desired nanoscale features and achieving high throughput.11 
Consequently, the development of new technologies tackling 
some of these challenges could significantly accelerate the 
clinical translation of nanomedicines.11
Microfluidic systems are a powerful tool to carry out a wide 
range of chemical reactions, and their use in the synthesis of 
NPs is attracting a remarkable interest on account of the inher-
ent properties associated with microreaction technology:13 the 
small channel dimensions lead to a relatively large surface 
area-to-volume ratios and increased driving forces for heat 
and mass transport. Thus, compared to conventional batch 
synthesis, microfluidic systems allow a precise control of 
the reaction conditions (reaction time, temperature, reactant 
concentration, and stoichiometry). Their high surface-area-
to-volume ratios and mixing characteristics help to reduce 
or avoid temperature and concentration heterogeneities, 
decreasing NP polydispersity, and guaranteeing a specific 
composition and structure. Because of the accurate control 
and reproducibility of physicochemical properties achieved 
by microfluidic systems, they are considered as the technol-
ogy of choice for mass production of nanomaterials.11
In this regard, controlled synthesis of polymeric NPs 
by rapid mixing in microfluidic platforms has been shown 
to improve their homogeneity and physicochemical 
properties.14–16 Microchannel emulsification was introduced 
as a novel emulsification method less than 2 decades ago.17 
This method produces monodisperse droplets with a poly-
dispersity below 5%, with the distinguishing feature that no 
shear forces are needed compared to the traditional batch 
production where ultrasonic or mechanical (ie, homogenizer) 
forces are needed. This fact is highly remarkable if the 
payload in the NPs is subjected to thermal or shear-sensitive 
degradation. However, besides the continuous production 
mode of microfluidic reactors, the throughput required 
to fulfil the clinical translation is still a challenge, and 
high-throughput procedures are highly desired. For instance, 
in vitro drug delivery studies require low amounts of NPs 
(eg, ∼50 μg/well), but the subsequent in vivo studies require 
significantly larger amounts (eg, ∼5 mg/mouse).15 This 
means that single microfluidic reactors with a typically low 
productivity (,0.3 g/h)15 fall short in the production rates 
that are typically required for clinical studies and industry. 
However, parallelization of NP synthesis by 3D hydrody-
namic flow focusing using PDMS-based microfluidic systems 
can improve the production rates up to 84 mg/h.15 However, 
those systems require sophisticated fabrication procedures, 
and the lack of robustness at high flow rates turns these 
designs unappropriated for long-term use. Recently, a glass 
flow focusing reactor16 and 3D hydrodynamic flow focusing 
microfluidic reactor fabricated in polyimide,18 a more durable 
material, enhanced the productivity of polymeric PLGA NPs 
achieving production rates of ∼10 g/h. New millifluidic reac-
tors based on coaxial turbulent jet mixers have also arisen 
to address the insufficient production of NPs, achieving a 
throughput as high as 126 g/h.19 However, this type of mixer 
is extremely sensitive to the hydrodynamic focusing of 
streamlines, and if the inner coaxial tubing is poorly aligned 
during fabrication, the resulting NPs would differ from the 
expected results.20 Consequently, a different type of micro-
fluidic reactor exploiting the advantages of the reported ones 
should contribute to clinical translation.
Here, a simple interdigital micromixer is demonstrated, 
which is mechanically durable and easy to operate and still 
enables high production rates close to 10 g/h, which are 
suitable for in vivo studies and large-scale production of 
drug-loaded NPs. In addition, this microfluidic reactor retains 
the advantages of processing small volumes: homogeneity, 
reproducibility, and control over the NP properties. The 
synthesis conditions promoted zero reactant adsorption on the 
channel surfaces and no particle aggregation, thus rendering 
it appropriated for continuous production. In addition, we 
have studied both the importance of passive mixing and the 
influence of the geometry analyzing various mixing junctions 
by evaluating the physicochemical properties of the resulting 
NPs. The mixing process within the microfluidic junctions 
was further analyzed by computational fluid dynamics (CFD) 
modeling in order to understand the hydrodynamic process 
and its implication for the polymeric NPs formation and to 
validate our experimental data.
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Materials and methods
reagents
The following reactant materials were used in the experi-
ments: polymer poly(d,l-lactic acid/glycolic acid) 50/50 
(PLGA; molecular weight 38–54 kDa), under the commercial 
name Resomer® RG 504, which was purchased from Evonik 
Industries AG (Darmstadt, Germany). Drugs cyclosporine 
A and dexamethasone (used as HPLC internal standard), 
surfactant Pluronic® F-68, and the solvents ethyl acetate, 
acetonitrile, and methanol (HPLC grade) were supplied by 
Sigma-Aldrich Co. (St Louis, MO, USA) and were used as 
received without further purification. All references to water 
imply the use of Milli-Q water previously filtered through a 
0.2-μm cellulose nitrate membrane.
synthesis of Plga NPs in batch reactors
PLGA NPs were prepared by the oil-in-water (O/W) emulsion 
solvent evaporation method. In this method, 50 mg of the 
polymer PLGA (50:50) and 150 mg of Pluronic F68 used as 
surfactant were dissolved in 5 mL of ethyl acetate. The organic 
phase was then emulsified with 10 mL of Milli-Q water used 
as aqueous phase. This mixture was sonicated in an ice bath 
for 25 seconds with a sonicator (Digital Sonifier 450; Branson 
Ultrasonics, North Olmsted, OH, USA) using a probe of 3 
mm diameter and 40% amplitude. After the formation of a 
stable emulsion, the organic solvent was evaporated under 
continuous stirring (600 rpm) for 3 hours. The same protocol 
was followed for the scaled-up experiments.
synthesis of Plga NPs in microreactors
PLGA NPs were prepared by O/W microchannel emulsifica-
tion process and solvent evaporation method. Approximately 
200 mg of polymer PLGA (50:50) and 600 mg of Pluronic 
F68 used as surfactant were dissolved in 20 mL of ethyl 
acetate (organic solvent). The organic phase was then intro-
duced in a plastic syringe (Q
O
) and emulsified with Milli-Q 
water (Q
A
) fed with another plastic syringe, using different 
flow ratios by the aid of a syringe pump (Harvard Apparatus, 
Holliston, MA, USA). Both the solutions were fed through 
a 1/16″ OD PTFE tubing and then mixed inside different 
Polyether ether ketone (PEEK) junctions or in the PEEK-
based interdigital micromixer (Micro4 Industries GmbH, 
Mainz, Germany). The temperatures of Q
O
 and Q
A
 streams 
were monitored and modified accordingly. Emulsification 
temperature of 14°C was obtained by mixing the aqueous 
and the organic streams both at 14°C, and emulsion tempera-
ture of 17.5°C was reached by mixing the aqueous and the 
organic streams at 14°C and 24°C, respectively. Emulsion 
temperature of 22°C was reached by mixing both streams at 
room temperature. After the formation of a stable emulsion, 
the organic solvent was evaporated under continuous stirring 
(600 rpm) in an open flask during 3 hours.
Cyclosporine-loaded PLGA NPs were prepared by 
following the same protocol mentioned earlier, but by 
dissolving the drug (10% w/w) in the organic phase before 
the formation of the emulsion. See additional details in the 
Supplementary materials.
characterization techniques
Determination of NP morphology
Electron microscopy observations were carried out at the 
LMA-INA-Universidad Zaragoza facilities. Scanning elec-
tron microscopy (SEM, Inspect F50; FEI, Eindhoven, the 
Netherlands) at an accelerating voltage of 10–15 kV was 
employed to determine the size (100 NPs were measured 
for performing the statistical analysis) and morphology of 
the synthesized NPs. The freshly prepared NPs were mixed 
during 1.5 hours with the same volume of phosphotungstic 
acid solution (7.5% w/v) used as contrast agent. The disper-
sion was centrifuged and washed three times with Milli-Q 
water and later resuspended. A drop of the resulting NP 
suspension was placed on a glass slide, dried in air, and coated 
with platinum under vacuum before SEM observation.
Transmission electron microscopy (TEM) observations 
were carried using a T20-FEI microscope with a LaB6 electron 
source fitted with a “SuperTwin®” (FEI Company, Hillsboro, 
OR, USA) objective lens allowing a point-to-point resolution 
of 2.4 Å. Approximately 2.5 μL suspension of stained PLGA 
NPs was pipetted onto a transmission electron microscopy 
copper grid with a continuous carbon film. Samples were let 
to evaporate completely and then were analyzed.
size and size distribution measurement
NP size and size distribution were determined by Dynamic 
Light Scattering (Zeta Plus; Brookhaven Instruments 
Corporation, NY, USA) after appropriate dilution with 
Milli-Q water. At least five replicate measurements were 
recorded in each case.
Entrapment efficiency of cyclosporine A
The drug content in NPs was determined directly by 
measuring the encapsulated cyclosporine amount in PLGA 
NPs. A known quantity of NPs was dissolved in acetonitrile 
mixed for 1 hour with the internal standard (dexamethasone). 
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Then, methanol was added into the mixture and mixed in an 
ultrasonic bath for 15 minutes to enhance PLGA precipitation. 
The dispersion was centrifuged at 12,000 rpm for 20 minutes 
to remove the polymeric residue, and the supernatant was fil-
tered using 0.22-μm PTFE syringe filters and placed in a vial 
for HPLC analysis. Experiments were performed in triplicate. 
Cyclosporine A content was determined by HPLC (Waters 
Instrument 2690 Alliance, Milford, MA, USA). A Kinetex 
C18 column with a 2.6 μm of filler particle size and dimen-
sions of 50×4.6 mm was used. The mobile phase consisted of 
a 80:20 (v/v) mixture of acetonitrile:water and a phosphoric 
acid concentration of 200 ppm. The detector wavelength, 
injection volume, flow rate, and column temperature were 210 
nm, 5 μL, 0.5 mL/min, and 70°C, respectively. The HPLC 
method was validated with respect to linearity, repeatability, 
limit of quantitation, and limit of detection.
Drug encapsulation efficiency (EE) was calculated using 
the following equation:
 
EE (%)
Amount of drug loaded
Total amount of drug added
= ×100
 
cFD study
Numerical models
CFD simulations were performed using the ANSYS FLUENT 
16.0 pressure-based segregated double precision solver.21 The 
volume of fluid method was used to determine the position of 
the interface between the aqueous and organic phases. The 
flow inside the interdigital micromixer (inner volume =8 μL) 
was defined by the unsteady three-dimensional Navier–
Stokes equations, assuming the hypothesis of continuous, 
Newtonian fluid and laminar flow.
The temporal term was discretized using a first-order 
implicit scheme. The Pressure Staggering Option scheme22 
was applied for interpolation of pressure gradient and A 
quadratic upwind interpolation scheme23 for discretiza-
tion of convective terms. Pressure and velocity fields were 
coupled by the Pressure Implicit with Splitting of Operator 
algorithm.24,25 The convergence criterion was set as 10-3 for 
all variables and 10-6 for energy. Approximately 100 itera-
tions were calculated in each time step. The time step size 
was set to 10-5 seconds.
The volume fraction equation was solved in an explicit 
manner at the beginning of each time step. Parabolic velocity 
profiles were considered at the inlets to yield the calculated 
mass flow rates described in the “Results and discussion” 
section. The initial temperature of the water stream was set 
at 287.15 K and the temperature of the organic stream at 
297.15 K. At the wall of the microreactor, nonslip boundary 
conditions were imposed on the velocity components, the 
contact angle was set at 70°, while the thermal boundary 
condition imposed a conductive resistance through the PEEK 
wall (having a thickness of 0.794 mm and a thermal conduc-
tivity of 0.25 W/m⋅K) and a constant outside temperature 
of 273.15 K, since the micromixer was submerged into an 
ice bath. Fluid properties were linearly interpolated with 
temperature among the values compiled in Table S1. It is 
important that the modeled simulation is a simplified model 
of the real scenario where a polymer with different nature 
(a hydrophobic lactic acid part and a hydrophilic glycolic 
acid part) is dissolved in an organic solvent under the pres-
ence of an amphiphilic molecule (surfactant). Hence, in our 
model only two phases, an aqueous and an oily phase, were 
considered to simplify the conditions.
The surface tension was set to 0.0239 N/m. At the outlet, 
variables were extrapolated from the values at the adjacent 
cell centroids, assuming a zero diffusion flux. The mesh 
was composed of 1,889,480 hexahedral cells for the case 
of micromixer, 159,156 quadrilateral cells for T junction, 
159,156 mixed cells for Y junction, and 161,757 quadrilateral 
cells for the cross junction.
Results and discussion
continuous production of Plga NPs 
by emulsification
The most widely used method to produce PLGA NPs is 
based on the O/W emulsification–evaporation process of a 
mixture of an organic dissolved polymer and a surfactant 
using water as antisolvent.26 The dispersion method used to 
prepare the emulsion is directly related to the particle size and 
morphology. Highly energetic homogenization techniques, 
such as probe sonication, have been used to effectively 
reduce the particle sizes ,1 μm. In this study, a well-known 
batch-modified synthesis method27 was reproduced, which 
renders good quality PLGA NPs with sizes (measured by 
DLS) approximately 128.1±4.7 nm after only 25 seconds of 
energetic sonication using a sonotrode in a reaction volume 
of 15 mL. We then attempted to scale up the production to 
different reaction volumes, up to a factor of 20 (150 and 
300 mL), but heterogeneous particle distributions with 
medium particle sizes of 464±100 nm and 1,119±300 nm 
(measured by SEM) with reactor volumes of 150 and 300 mL, 
respectively, were obtained (Figure S1). These results 
clearly show that the emulsification process works well for 
small batches, but scale-up is difficult. As the intensity of the 
ultrasound in a liquid decreases rapidly with the distance 
to the sonotrode, larger volumes may not be well homog-
enized, promoting a heterogeneous distribution of acoustic 
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waves. Besides the limited production obtained by ultra-
sonic emulsification, this approach is mainly driven by 
cavitation. Consequently, ions or particles can be emitted 
into the product by cavitational abrasion of the sonotrode 
since they consist of metallic alloys, promoting a feasible 
product contamination.28 In addition, high-energy inputs 
involved during the ultrasonic emulsion could also induce 
the loss of the functional properties of thermal or shear-
sensitive encapsulated molecules. Consequently, alternative 
production approaches are demanded to enable a scaled-up 
production.
The shear stress produced at the interphase of immis-
cible liquid microflows is energetic enough to promote the 
emulsion formation without the need of external mechanical 
or ultrasonic forces.14 Passive mixing by the reduction of 
the diffusion distance allows a rapid diffusive mixing with 
time scales ranging from tens to hundreds of milliseconds.29 
Nevertheless, the grade of mixing and shear stress not only 
depend on the fluid properties, the diffusion distance or 
linear velocity, but also on the stream layout.30 Figure 1 
shows a comparative study of PLGA production when the 
emulsion precursor streams were mixed at different contact 
angles using three different micromixers. Two separate 
phases were obtained at low flow rates (,95 mL/min) after 
mixing at the assessed junctions. The formation of a milky 
white dispersion, characteristic of emulsion formation, was 
obtained at a mean velocity .8 m/s (Figure S2). This con-
firms that the shear stress generated at the mixing unit is an 
essential variable to generate emulsions. In those mixers, the 
initial emulsion is broken down sequentially forming a fine 
emulsion in which the polymer hardens after organic solvent 
diffusion toward the aqueous media (Figure 2). In fact, the 
particle size distribution of emulsified PLGA NPs decreased 
as the total flow rate increased (Figure S3). For instance, the 
PLGA NPs produced at a residence time of 0.5 millisecond, 
when the aqueous and the organic streams were mixed in a 
Y junction, were highly polydisperse (1,499±743 nm, mea-
sured by SEM; Figure 1A). The mixing, and consequently 
the PLGA particle size distribution, was improved when the 
inlet configuration was changed to a T junction. However, 
this particle-size distribution was also sensitive to the inlet 
configuration. The system where the two inlets (Q
O
 and Q
A
) 
were introduced counter current along the top arm of the 
T-micromixing unit enabled to narrow down the PLGA size 
distribution (972±469 nm, measured by SEM; Figure S3) 
in comparison with the configuration where the disperse 
phase (Q
O
) entered the micromixing unit via the side arm, 
with the continuous phase introduced through the top arm 
(1,024±448 nm, measured by SEM; Figure 1B).
Finally, the best results were obtained at the 
cross-micromixing unit (Figure 1C). The tangential injection 
of the continuous phase enables the confinement of the 
disperse phase and maximizes the interface mixing, which 
enables to decrease the particle size distribution (measured by 
SEM) up to 927±467 nm. Then, the lamination of the aque-
ous and organic phases reduces the polydispersity of PLGA 
emulsified NPs.
Considering the previous results, the use of a multil-
amination (interdigital) micromixer, where the microchan-
nel dimensions (45 μm width) were thinner that the cross 
junction unit, was proposed. These dimensions should 
promote the production of monodisperse NPs because of an 
improved mixing and the higher shear stress produced at the 
microchannel junctions (Figure 2). Figure 3 shows the slit 
interdigital micromixer selected to fulfil the aforementioned 
requirements. Each input flow (Q
A
 and Q
O
) diverges into 
16 slits where Q
O
 and Q
A
 laminate following a 90° trajectory 
to accelerate the mixing of reagents and promoting high shear 
stress (Figure 3A–D). Finally, the streams flowed out and 
converged into an outlet.
In agreement with the results obtained at Y, T, and 
cross-micromixing junctions, by simply varying the mixing 
time from 20 to 10 milliseconds, the size of the produced 
NPs can be reproducibly controlled in a range of 700–300 
nm, respectively (Figures 3A and B and S4). The results 
were in agreement with the previous analysis carried out for 
PLGA microparticles where Freitas et al31 showed that larger 
mixer diameters produced larger particles when using pas-
sive mixers. The mixing time can be estimated in the range 
of 6 milliseconds, using a two-dimensional flow focusing 
hydrodynamic equation14 (Equation 1).
 
τ
mix
w
D
R
≈
+


2
2
1
1
1
 
(1)
where D is the diffusivity of the solvent (10-9 m2/s), w is the 
microchannel width, and R is the ratio of flow rate of the 
organic stream to the total flow rate of water.
Then, it seems reasonable that the best control on par-
ticle size is achieved at 10 milliseconds of residence time 
because higher flow rates increase local mixing and thus 
smaller particles can be produced. A fast flow induced a 
fast convective mixing, avoiding the generation of larger 
particles because of the much faster mixing time relative 
to the aggregation time as compared to a slow diffusive 
mixing.18
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Figure 1 Microfluidic junctions used for the continuous PLGA nanoparticle production.
Notes: Schematic of flow streams at the mixing junction and representative SEM images of produced NPs: (A) Y junction, (B) T junction, and (C) cross junction. QO = organic 
phase flow, Qa = aqueous phase flow. Qa1+Qa2=Qa=2QO=62.8 ml/min. histograms retrieved from seM measurements.
Abbreviations: NP, nanoparticle; Plga, poly(d,l lactic-co-glycolic acid); seM, scanning electron microscopy; sD, standard deviation.
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Figure 2 Schematic interpretation of a microchannel emulsification process.
Notes: The emulsion is sequentially broken down by shear stress in the microfluidic 
systems applied in this work: (A) mixing junctions and (B) interdigital micromixer.
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Figure 3 The slit interdigital micromixer.
Notes: (A) Interdigital micromixer. The inset shows the inlet (QO and Qa) and outlet streams. (B) Geometry of the inlet stream to assure an equalized flow distribution into 
the mixing microchannels. (C) Mixing microchannels at the QO and Qa inlet zone. (D) Detail of a mixing microchannel with a rectangular cross-section. (E and F) Micromixer 
scheme for cFD modeling.
Abbreviation: CFD, computational fluid dynamics.
For intravenous or topic delivery of soft biodegradable 
NPs, particle sizes of ,300 nm are a requirement.32 However, 
under those conditions and using the interdigital micromixer, 
the NP size could not be decreased under 300 nm since a 
mixing time ,10 milliseconds increased the set-up pressure 
drop and modified the flow regime from laminar to turbulent. 
The size of the droplet is determined by a competition 
between the pressure due to viscous shear stresses and the 
capillary pressure resisting deformation, both related in the 
dimensionless capillary number (Ca) (Equation 2).
 
Ca
w o
= ×ν µ
σ
–  
(2)
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where ν is the mean velocity at the channel section, μ is 
the dynamic viscosity and σ
w–o
 is the surface tension at the 
water–oil interphase.
For Ca .0.01, the shear action by the continuous 
phase on the emerging dispersed phase is the dominating 
mechanism,33 which promotes the formation of homogenous 
polymer NPs. It is generally accepted that if the mixing 
temperature is conveniently decreased, the viscous shear 
stress can be increased over the capillary pressure, promot-
ing a decrease in the particle size.33,34 Figure 4 shows that 
the mean particle size can be considerably decreased when 
the mixing unit was placed in an ice bath at 4°C, decreasing 
the emulsification temperature from 24°C to 22°C. This 
continuous emulsification at 22°C enables the production of 
polymeric NPs with mean sizes below 300 nm (215±67 nm, 
measured by SEM) (Figure S5). Besides the well-known heat 
transfer of microfluidics, the fluid temperature was vaguely 
decreased by 2°C (inlet temperature was set at 24°C) through 
the residence time of 10 milliseconds, due to the fast flow of 
precursors through the micromixer. Then, the temperature of 
the inlet streams was modified before the mixing in order to 
credit the key role of shear stresses and capillary forces on 
the resulting sizes of the PLGA NPs. The temperature of Q
O
 
stream was set at 22°C to prevent the potential precipitation 
of the polymer and surfactant dissolved and the consequent 
blockage of the microreactor. The temperature of the Q
A
 was 
set at 24°C, 14°C, and 8°C, obtaining an emulsion stream 
at 22°C, 17.5°C, and 14°C, respectively. Figure 5 depicts 
the PLGA NPs produced at Q
A
 temperature of 24°C, 14°C, 
and 8°C. The particle size distribution analysis and transmis-
sion electron microscopy images confirm that decreasing 
the emulsion temperature from 22°C to 17.5°C enables to 
produce the smallest PLGA NPs (220±54 nm, measured by 
SEM) as well as the narrowest size distribution (Figure 5). 
If the emulsification temperature was further decreased to 
14°C, the NP average size and distribution were not well 
controlled (535±296 nm). This trend can be justified by the 
lower solubility of reagents in the reaction media and the 
notable increase in the calculated surface tension (∼30%) 
(Table 1). These results show that there is an optimum tem-
perature to decrease the size of PLGA NPs. The optimum 
temperature is the result of a balance between the viscous 
Figure 4 SEM images of PLGA nanoparticles produced by microchannel emulsification in a interdigital micromixer at different conditions.
Notes: (A) 20 ms, Qa = 2QO, Tª emulsification =22°c; (B) 10 milliseconds, Qa =2QO, Tª emulsification =22°c; (C) 10 milliseconds, Qa =2QO, Tª emulsification =24°c; 
(D) 10 milliseconds, Qa =3QO, Tª emulsification =22°c.
Abbreviations: Plga, poly(d,l lactic-co-glycolic acid); seM, scanning electron microscopy.
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Figure 5 SEM and TEM images of PLGA nanoparticles produced by microchannel emulsification in a interdigital micromixer at different conditions.
Notes: (A) 10 milliseconds, Qa =2QO, Tª emulsification =14°c; (B) 10 milliseconds, Qa =2QO, Tª emulsification =17.5°c; (C and D) TEM images: 10 milliseconds, Qa =2QO, 
Tª emulsification =17.5°c; (E) 10 milliseconds, Qa =2QO, Tª emulsification =17.5°c and solvent evaporation using a magnetic stirrer (600 rpm) at rT; (F) 10 milliseconds, 
Qa =2QO, Tª emulsification =17.5°c and solvent evaporation using a rotavapor at rT.
Abbreviations: Plga, poly(d,l lactic-co-glycolic acid); rT, room temperature; seM, scanning electron microscopy; TeM, transmission electron microscopy.
?
???? ????
??????
??????
??????
??????
???? ????
?
? ?
? ?
shear stress and the surface tension, both related in the Ca 
number.
Regarding the residence time contribution in the con-
tinuous emulsification process, the interdigital microreactor 
corroborated the same findings observed in Y, T, and cross 
junctions. The independent injection of Q
O
 and Q
A
 phases 
at the microfluidic reactor enabled a fast screening of the 
proper synthesis conditions. The ratio of Q
A
/Q
O
 was varied to 
study the effect of modifying the proportion of the dispersed 
phase during the emulsification process. Figures 4B and D 
and S5 show that the best results were obtained when the 
Q
A
/Q
O
 was 2. This circumstance could be attributed to the 
fact that the viscous force becomes less important as Q
A
 
increases.
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On the other hand, it was also observed that the procedure 
followed to evaporate the solvent from the PLGA NPs was 
directly related with the final NP morphology. The vacuum 
rotative evaporation is usually more efficient in the polymer 
precipitation process than other evaporation methods since 
the rate of diffusion of the organic solvent through the 
solvent interphase is maximized.35 However, an increase in 
the particle size by a coalescence phenomenon as well as 
the presence of collapsed NPs was observed when using the 
rotavapor (Figure 5D).
On the contrary, the use of magnetic stirring at high speed, 
600 rpm, still enabled a fast solvent displacement, evapora-
tion, and polymer precipitation and hardening in a short time, 
but without altering the NPs morphology.
As mentioned earlier, biodegradable PLGA polymeric 
NPs have received considerable attention in nanomedicine 
as carriers for targeted and controlled delivery of therapeutic 
and diagnostic agents.36 As proof of concept, the interdigital 
micromixer was considered to easily encapsulate a therapeu-
tic drug, cyclosporine, normally used to prevent transplant 
rejection. Cyclosporine was encapsulated in PLGA NPs in 
a continuous manner by using the interdigital micromixer 
by premixing the therapeutic drug in the polymeric NP pre-
cursor (Figure 6). No significant differences were observed 
while comparing the sizes of empty PLGA NPs with the 
ones loaded with cyclosporine, obtaining a mean particle of 
211±62 nm (measured by SEM). The drug EE, defined as the 
percentage of initial drug which is encapsulated size in the 
NPs, was considerably high (91±5%) out of three runs. Con-
sequently, the EE was highly reproducible which is of great 
importance since discontinuous production in batch-type 
reactors suffer from a considerable irreproducibility.11 This 
results are similar to the ones recently reported by Liu et al16 
using a nanoprecipitation process instead of emulsification 
to encapsulate drugs in PLGA.
cFD simulation
A CFD simulation was carried out to elucidate the flow 
pattern under the different synthesis conditions and stream 
arrangements to corroborate our experimental observations. 
The study proved to be useful for visualizing the flow patterns 
in opaque microchannels allowing us to make a correlation 
Figure 6 Micrographs of cyclosporine-encapsulated Plga NPs.
Notes: (A) seM and (B) TeM.
Abbreviations: NP, nanoparticle; Plga, poly(d,l lactic-co-glycolic acid); seM, scanning electron microscopy; TeM, transmission electron microscopy.
? ?
??????
??????
?????
????
Table 1 Summary of the physical properties of the organic stream and the emulsion formed at Qa/QO =2
Temperature (°C) Density  
(g/cm3)
Emulsion surface  
tension (mN/m)
Dynamic viscosity  
(mPa⋅s)
Emulsion  
(Ca)
14 0.918 4.60 1.08 0.90
15 0.916 4.21 1.06 0.97
17.5 0.913 4.03 1.01 0.97
20 0.911 3.89 0.97 0.98
22 0.908 3.60 0.95 1
Notes: Temperature, density, and dynamic viscosity are referred to the organic phase.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
15
5.
21
0.
59
.2
16
 o
n 
30
-A
ug
-2
01
6
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2016:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3407
continuous synthesis of drug-loaded Plga nanoparticles
among the different operating conditions and the size of the 
NPs obtained.
Two inlet streams, organic (Q
O
) and aqueous (Q
A
), were 
considered. The properties and flow rates used were those 
experimentally determined to be optimum (Q
A
 =32 mL/min, 
Q
O
=16 mL/min) to produce the NPs with a low 
polydispersity.
As an indicator to correlate particle size with simula-
tion data, we used the degree of mixing, as we consider 
that improving the mixing enables a great uniformity in 
the sizes of the NPs due to the interphase shear stress that 
has been generated (Figure 2). According to inlet streams 
composition, the optimum mixing point at the microchan-
nel emulsification should be considered when the outlet 
stream composition was approximately 66% of aqueous 
phase (volume fraction) and 33% of organic phase (vol-
ume fraction), which also correlates with the PLGA cloud 
point.37 The validation of the experimental results obtained 
with micromixing junctions confirms that mixing criteria 
is a key parameter to understand the PLGA emulsification 
process. The simulation shows that the most viscous fluid 
(Q
O
) was detached from the walls and was unsheathed by 
the less viscous fluid (Q
A
), causing a progressive increase 
in the surface-to-volume ratio of the contact interface. This 
behavior results in a fast mixing, high shear stress, and thus 
smaller and less polydisperse PLGA NPs. Figure 7A–C 
depicts the CFD contours of volume fraction of each 
micromixing junction used, confirming that the mixture 
was enhanced in the cross junction in comparison with the 
Y and T junctions. However, the presence of areas where 
the organic stream was not unsheathed by water was still 
observed. This lack of mixing control can consequently sup-
port high polydispersity and large particle size of the NPs 
produced with those micromixing junctions. On the other 
hand, the CFD study reveals that the mixing grade of Q
O
 and 
Q
A
 was considerably improved in the interdigital micro-
mixer (Figure 7D), achieving a fast mixing that promotes 
the controlled production of PLGA NPs. Consequently, the 
experimental results previously stated credit the computa-
tional fluid dynamic analysis.
Figure 7 Contours of volume fraction (aqueous phase) modeled in micromixing junctions.
Notes: at 5×10-2 seconds in a T junction (A), cross junction (B), and Y junction (C), and at 6×10-3 seconds in the interdigital micromixer (D). The color scale shows the 
volume fraction of aqueous phase. (E) Interdigital micromixer. green surfaces comprise the modeling computational sections (Int_0→1300 μm). The separation distance 
between sections is 50 μm. Microchannel emulsification at 14°c. Volume fraction of aqueous phase at the section Int_0050, Int_0250, and Int_0750 μm at an elapsed time 
shorter than the optimum mixing time: (F–H) 5.7×10-3 seconds and longer than the optimum mixing time (I–K) 1.17×10-3 seconds.
?
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? ? ?
? ? ? ?
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To further demonstrate the correlation between shear 
stress/mixing process and resulting monodispersity in the 
NPs produced as a function of the emulsification temperature, 
the flow focusing outlet stream of the interdigital micromixer 
was divided into 26 sections (from z=0 μm (Int_0000) to 
z=1,300 μm (Int_1300). The distance between the sections 
was 50 μm (Figure 7E and Supplementary materials for more 
details on the numerical model). Simulations of the aqueous 
volumetric fraction in the different flow focusing sections 
show that a uniform mixing was achieved at the downstream 
section Int_0500. The variation in mixing performance regard-
ing the emulsification temperature is evident from Figure 8A; 
the elapsed time required to achieve a steady state was shorter 
at 24°C (5×10-3 seconds) than at 14°C (7×10-3 seconds), which 
is reasonable in terms of diffusive mixing enhancement.38 
On the other hand, the mixing performance along the different 
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Figure 8 results of map analysis. Variation of the % area with an aqueous volumetric fraction similar to the optimum mixing point (aqueous volume fraction =66%) 
(A) along several sections (Int_0000, Int_0250, Int_0500, Int_0750, and Int_1000 μm) at 14°c and 24°c. (B) evolution of distribution of aqueous volumetric fraction in 
section Int_0750.
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sections was studied by two-dimensional concentration color 
maps (Figures 7 and S6). The map analysis evidences that 
the section area percentage with a volumetric fraction close 
to the optimum mixing point is higher at 14°C (15%) than at 
24°C (10%; Figure 8A). Figures 7F–K and S7 compare the 
two-dimensional volumetric fraction maps at 14°C and 24°C 
in sections Int_0050, Int_0250, and Int_0750 at a transient 
and steady elapsed state, respectively. It can be observed that 
the variation in the mixing performance is evident at 5.7×10-3 
seconds and 1.17×10-2 seconds.
The most viscous fluid (Q
O
) was unsheathed, achieving 
a surface area interface at the section Int_0750. It should be 
highlighted that a high surface area interface is required to 
promote a high shear stress between the aqueous and oily 
phases, as well as to induce the sequential break down of 
the emulsion (Figure 2). The aqueous volumetric fraction 
in terms of % area with similar composition at the section 
Int_0750 μm is presented in Figure 8B, achieving both 
a homogenous and fast mixing in a short time. It can be 
observed that initially the flow-focusing channel contains 
only the aqueous phase, which is mixed with the organic 
phase over time. The area related with 100% of aqueous 
volume fraction is decreased with elapsed time, arising the 
profiles related to the unsheathed organic phase. It can also be 
inferred from Figure 8B that the optimum conditions to gen-
erate a stable emulsion (%H
2
O v/v ,60) are highly dependent 
on the elapsed time. Consequently, the simulations carried 
out in the flow-focusing section of the interdigital micromixer 
remark the influence of the emulsification temperature as 
well as the elapsed time in the mixing performance. Both the 
findings are in full agreements with the experimental results 
obtained, which implies that the proposed computational 
model is powerful enough to predict the evolution of the 
mixing during the microchannel emulsification.
Conclusion
In summary, using the O/W emulsification–evaporation 
technique, monodisperse PLGA NPs can be prepared by 
controlling the fluid flow conditions and temperatures of the 
mixing streams interfaced in interdigital micromixers. The 
shear stress between the mixing streams in the microchannels 
is enough to generate stable emulsions without the need of 
mechanical or sonic disruption. Low temperatures and lami-
nar flow regimes (Re
H2O
 =1,193) rendered highly monodis-
perse NPs with a high throughput production. In microfluidic 
channels, the NP size can be modified depending on the 
Re number used. The optimum synthesis temperature is a 
result of the balance between the viscous shear stress and 
the surface tension in the microchannels. Three-dimensional 
CFD simulations represent a valuable tool to gain insight 
into the understanding of the mixing phenomena during 
emulsification–evaporation processes. Both simulations and 
experimental results supported the production of drug-loaded 
monodisperse PLGA NPs.
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Supplementary materials
synthesis of poly(d,l lactic-co-glycolic 
acid) nanoparticles loaded with 
cyclosporine
Cyclosporine–poly(d,l lactic-co-glycolic acid) (PLGA) 
nanoparticles (NPs) were prepared using an Interdigital 
micromixer by oil-in-water microchannel emulsification 
process and solvent evaporation method. Briefly, 1% (w/v) 
of polymer PLGA (50:50), 0.1% (w/v) of cyclosporine and 
3% (w/v) of Pluronic F68 used as surfactant were dissolved 
in 30 mL of ethyl acetate (organic solvent). The organic phase 
was then introduced in a plastic syringe (Q
O
) and emulsified 
with MilliQ water (Q
A
) fed with another plastic syringe, using 
16 and 32 mL/min flow ratios, respectively, with the aid of a 
syringe pump (Harvard Apparatus). Both the solutions were 
fed through a 1/16″ OD PTFE tubing and then mixed inside 
different PEEK junctions or in the PEEK-based interdigital 
micromixer. The micromixer is placed in an ice bath to control 
the reaction temperature. After the formation of a stable emul-
sion, the organic solvent was evaporated under continuous 
stirring (600 rpm) in an open flask during 3 hours.
Entrapment efficiency of cyclosporine A
Drug content in NPs was determined directly by measur-
ing the encapsulated cyclosporine amount in PLGA NPs. 
Approximately 2.5 mg of PLGA–cyclosporine nanopar-
ticles were dissolved in 1.15 mL of acetonitrile mixed for 
1 hour with 100 μL of the internal standard (dexamethasone 
1,500 ppm). Then, 250 μL of methanol was added into 
the mixture and mixed in a sonifier bath for 15 minutes to 
enhance the PLGA precipitation. The dispersion was centri-
fuged at 12,000 rpm for 20 minutes to remove the polymeric 
residue, and the supernatant was filtered using 0.22-μm 
PTFE syringe filters and placed in a vial for HPLC analysis. 
Experiments were performed in triplicate.
Cyclosporine A content of the samples was determined 
by HPLC (Waters Instrument 2,690 Alliance, USA). A 
Kinetex C18 column with a filler particle of size 2.6 μm 
and dimensions of 50×4.6 mm was used. The mobile phase 
consisted of a 80:20 (v/v) mixture of acetonitrile:water and 
a phosphoric acid concentration of 200 ppm. The detec-
tor wavelength, injection volume, flow rate, and column 
temperature were 210 nm, 5 μL, 0.5 mL/min, and 70°C, 
respectively. The HPLC method was validated with respect 
to linearity, repeatability, limit of quantitation (LOQ), 
and limit of detection (LOD). The linearity range was 
30–200 μg/mL (r2 =0.9995) and the LOD and LOQ were 
8.23 and 24.70 μg/mL, respectively.
Table S1 Fluid properties used in the simulations
Solvent used T (K) ρ (kg/m3) Cp (J/kg K) K (W/m⋅K) μ (kg/m⋅s)
h2O 278.15 1,000 4,201 0.558 0.00152
303.15 995.7 4,181 0.603 0.000798
ethyl acetate 278.15 918.4 1,590 0.111 0.00108
303.15 916.8 1,590 0.111 0.00106
????
??? ?
????
? ?
Figure S1 (Continued)
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? ?
??????????????????? ???? ????????????????????????????????????????????????????????????
????????????????????????????
?????????? ?? ???
?? ???
?? ???
?? ??
??????????
??????????????
???????????????????????
?
Figure S2 Depending on the conditions, formation of a milky white dispersion, characteristic of emulsion formation, or obtaining two segregated phases.
Notes: PLGA outlet stream produced with a T junction: (A) total flow rate 20–90 mL/min. Two segregated phases were obtained. (B) Total flow rate .95 ml/min. a single 
phase emulsion was obtained. (C) synthesis conditions and microchannel dimensions to produce stable Plga emulsions.
Abbreviation: Plga, poly(d,l lactic-co-glycolic acid).
Figure S1 seM micrographs of Plga nanoparticles synthesized at different scale-up production volumes using a conventional batch reactor.
Notes: (A and B) 15 ml, (C and D) 150 ml, and (E and F) 300 ml.
Abbreviations: Plga, poly(d,l lactic-co-glycolic acid); seM, scanning electron microscopy.
???? ?
???? ?
????
???? ????
? ?
? ?
????
??????????°?????????????? ?????????????????????????
? ? ??? ????? ????? ????? ?????
?
?
?
?
??
??
??
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????
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???
?
?????????????
???????????? ????? ?
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?
Figure S3 (Continued)
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?????????????????????
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?
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?
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?
Figure S4 seM, TeM micrographs and particle size distribution of Plga nanoparticles synthesized with an interdigital micromixer at different conditions.
Notes: (A) 20 milliseconds, (B) 10 milliseconds. Qa =2QO, emulsification Ta =24°c.
Abbreviations: Plga, poly(d,l lactic-co-glycolic acid); seM, scanning electron microscopy; TeM, transmission electron microscopy; sD, standard deviation.
Figure S3 SEM micrographs and particle size distribution of PLGA nanoparticles synthesized with the T junction at different residence times.
Notes: (A) 1 millisecond and (B) 0.5 milliseconds (48 and 95 ml/min, respectively). Ta =22°c. The histograms were elaborated by measuring the particle sizes from the 
seM images.
Abbreviations: min, minutes; Plga, poly(d,l lactic-co-glycolic acid); seM, scanning electron microscopy; sD, standard deviation.
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??????? ?????????? ?????????? ?????? ?????° ?????????? ?????????? ??????????????? ?????????? ?????????? ?????? ?????° ?????????? ?????????? ????????
Figure S6 seM micrographs and particle size distribution of Plga nanoparticles synthesized with an interdigital micromixer at 10 milliseconds.
Note: Qa=QO, emulsification Ta =24°c.
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Figure S7 Microchannel emulsification at 24°c.
Notes: Volume fraction of aqueous phase at the sections Int_0050, Int_0250, and Int_0750 μm at an elapsed time shorter than the optimum mixing time (A, C, E) 5.7×10-3 
seconds and longer than the optimum mixing time (B, D, F) 9.05×10-3 seconds.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
15
5.
21
0.
59
.2
16
 o
n 
30
-A
ug
-2
01
6
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
 MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2016:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
3416
Ortiz de solorzano et al
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
15
5.
21
0.
59
.2
16
 o
n 
30
-A
ug
-2
01
6
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
